GeneDx Holdings Corp. Asset Impairment Charges
GeneDx Holdings Corp. (WGS) reported Asset Impairment Charges of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AssetImpairmentCharges · last filed 2026-08-03
- GeneDx Holdings Corp. asset impairment charges for the quarter ending 2026-06-30 was $0.00.
- GeneDx Holdings Corp. asset impairment charges for the quarter ending 2026-03-31 was $31.29M.
- GeneDx Holdings Corp. asset impairment charges for the quarter ending 2025-06-30 was $0.00.
- GeneDx Holdings Corp. asset impairment charges for the quarter ending 2025-03-31 was $0.00.
- GeneDx Holdings Corp. asset impairment charges for fiscal 2025 was $0.00.
- GeneDx Holdings Corp. asset impairment charges for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- GeneDx Holdings Corp. asset impairment charges for fiscal 2023 was $10.40M, a 95.05% decline from fiscal 2022.
- GeneDx Holdings Corp. asset impairment charges for fiscal 2022 was $210.15M.
| Period end | Asset Impairment Charges 3 month | Asset Impairment Charges 6 month | Asset Impairment Charges 9 month | Asset Impairment Charges 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-03 | $31.29M 10-Q · filed 2026-08-03 | ||
| 2026-03-31 | $31.29M 10-Q · filed 2026-05-04 | |||
| 2025-12-31 | $0.00 10-K · filed 2026-02-23 | |||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-03 | $0.00 10-Q · filed 2026-08-03 | $0.00 derived: sum of 3 quarters · filed 2026-08-03 | $0.00 derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-04 | $0.00 derived: sum of 2 quarters · filed 2026-05-04 | $0.00 derived: sum of 3 quarters · filed 2026-05-04 | $0.00 derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $0.00 derived: sum of 2 quarters · filed 2026-02-23 | $0.00 derived: sum of 3 quarters · filed 2026-02-23 | $0.00 10-K · filed 2026-02-23 |
| 2024-09-30 | $0.00 10-Q · filed 2024-10-29 | $0.00 derived: sum of 2 quarters · filed 2024-10-29 | $0.00 10-Q · filed 2024-10-29 | $0.00 derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-06-30 | $0.00 10-Q · filed 2024-07-30 | $0.00 10-Q · filed 2024-07-30 | $0.00 derived: sum of 3 quarters · filed 2026-02-23 | $8.28M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-03-31 | $0.00 10-Q · filed 2024-04-29 | $0.00 derived: sum of 2 quarters · filed 2026-02-23 | $8.28M derived: sum of 3 quarters · filed 2026-02-23 | $8.28M derived: sum of 4 quarters · filed 2026-02-23 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $8.28M derived: sum of 2 quarters · filed 2026-02-23 | $8.28M derived: sum of 3 quarters · filed 2026-02-23 | $10.40M 10-K · filed 2026-02-23 |
| 2023-09-30 | $8.28M 10-Q · filed 2024-10-29 | $8.28M derived: sum of 2 quarters · filed 2024-10-29 | $10.40M 10-Q · filed 2024-10-29 | $220.55M derived: sum of 4 quarters · filed 2024-10-29 |
| 2023-06-30 | $0.00 10-Q · filed 2024-07-30 | $2.12M 10-Q · filed 2024-07-30 | $212.26M derived: sum of 3 quarters · filed 2024-07-30 | $212.26M derived: sum of 4 quarters · filed 2024-07-30 |
| 2023-03-31 | $2.12M 10-Q · filed 2024-04-29 | $212.26M derived: sum of 2 quarters · filed 2024-04-29 | $212.26M derived: sum of 3 quarters · filed 2024-04-29 | $212.26M derived: sum of 4 quarters · filed 2024-04-29 |
| 2022-12-31 | $210.15M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $210.15M derived: sum of 2 quarters · filed 2024-02-23 | $210.15M derived: sum of 3 quarters · filed 2024-02-23 | $210.15M 10-K · filed 2024-02-23 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-03 | $0.00 derived: sum of 2 quarters · filed 2023-11-03 | $0.00 10-Q · filed 2023-11-03 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-09 | |||
| 2021-12-31 | $0.00 10-K · filed 2023-03-16 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |